RxDoctor Payments DataLook up a doctor →

Ann Groover, MD

Psychiatry · Calhoun, GANPI 1871664995

Payments from drug & device makers

$1,353,133in general payments, 2019–2025

Across 2,368 payments — averaging $571.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$533K
  • Vanda Pharmaceuticals Inc.$287K
  • Teva Pharmaceuticals USA, Inc.$275K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$142K
  • Axsome Therapeutics, Inc.$76K
  • Eisai Inc.$15K
  • plus $24K from 27 others
$48,586in research payments, 2019–2025

Across 98 payments — averaging $495.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Teva Pharmaceuticals USA, Inc.$49K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,353,133 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$158,884
Medicare patients
180
Services billed
1,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Calhoun

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →